Accession Number: | 0001209191-21-056526 |
Date: | 2021-09-14 |
Issuer: | DICE THERAPEUTICS, INC. (DICE) |
Original Submission Date: |
SCOPA JAMES PAUL
C/O DICE THERAPEUTICS, INC.
279 E. GRAND AVENUE, SUITE 300, LOBBY B
SOUTH SAN FRANCISCO, CA 94080
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-09-15 | P | 6,000 | a | $17.00 | 55,841 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 17.0 | 2021-09-14 | deemed execution date | A | 12,096 (a) | 2031-09-14 | common stock 12,096 | $17.00 | 12,096 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 17.0 | 2021-09-14 | deemed execution date | A | 8,261 (a) | 2031-09-14 | common stock 8,261 | $17.00 | 8,261 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 17.0 | 2021-09-14 | deemed execution date | A | 8,200 (a) | 2031-09-14 | common stock 8,200 | $17.00 | 8,200 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 17.0 | 2021-09-14 | deemed execution date | A | 5,600 (a) | 2031-09-14 | common stock 5,600 | $17.00 | 5,600 | direct |
ID | footnote |
---|---|
f1 | the number of shares of common stock reported in the reporting holder's form 3 reflected the conversion of derivative securities based on the midpoint of the issuer's initial public offering range of $16.00 per share. the number of shares of common stock reflected in this form 4 reflects the adjusted number of shares issued based on the higher initial public offering price of $17.00 per share, and does not reflect a disposition of shares. |
f2 | certain of the shares are subject to the issuer's right of repurchase if underlying vesting conditions are not met. |
f3 | the option vests as to 1/36th of the total shares monthly, beginning november 8, 2020, subject to the reporting holder's continued service to the registrant. |
f4 | the option vests as to 1/36th of the total shares monthly, beginning january 1, 2021, subject to the reporting holder's continued service to the registrant. |
f5 | the option vests as to 1/48th of the total shares monthly, beginning august 20, 2021, subject to the reporting holder's continued service to the registrant. |